SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Aarti Pharmalabs

BSE: 543748 29 Jun 2025
Healthcare
₹ 864.1
Aarti Pharmalabs Limited specializes in Pharmaceuticals within the Healthcare sector.

Aarti Pharmalabs - Share Price & Details

Market Cap
₹7,733
High /Low
950.0 / 521.0
Stock P/E
28.4
Book Value
₹220.0
Dividend Yield
0.35
ROCE
17.4
ROE
₹14.5
Face Value
5.0
PEG Ratio
NA
EVEBITDA
₹17.2
Debt
413
CMP / FCF
650.0
Debt to equity
₹0.21
NP Ann
272
High price all time
950.0
Piotroski score
₹6.0
Graham Number
385.0
No. Eq. Shares
9.06
Net CF
₹-16.9
Net profit
272
Price to book value
3.89
Interest Coverage
₹14.4
Low price all time
235.0
Industry PE
32.0
Reserves
₹1,945
Free Cash Flow
₹-112

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Aarti Pharmalabs Limited5271.19888.455296.249.87,73328.4
HealthCare Global EnterprisesNANANANA7595171.0
KOVAI MEDICAL CENTER & HOSPITANANANANA6170107.0

Peer Comparison Chart


About Aarti Pharmalabs

Aarti Pharmalabs Limited, with Security Code 543748, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Aarti Pharmalabs Stock Reaches All-Time High, Signaling Strong Sector Performance

(05 Jun 2025)
Aarti Pharmalabs has achieved an all-time high stock price, reflecting strong performance in the pharmaceuticals sector. The company has outperformed its...
Read more →

Aarti Pharmalabs Stock Reaches All-Time High, Signaling Strong Market Confidence

(29 May 2025)
Aarti Pharmalabs has reached an all-time high in stock price, demonstrating strong performance in the pharmaceuticals sector.
Read more →

Aarti Pharmalabs Achieves All-Time High Stock Price Amid Strong Financial Performance

(28 May 2025)
Aarti Pharmalabs has achieved an all-time high stock price, reflecting strong performance in the pharmaceuticals sector. The company has outperformed the...
Read more →

Aarti Pharmalabs Posts Strong Q4 FY25, Targets Robust Growth in FY25-26

(27 May 2025)
Aarti Pharmalabs Limited (APL), a leading manufacturer of active pharmaceutical ingredients (APIs), pharmaceutical intermediates and xanthine derivatives,...
Read more →

Aarti Pharmalabs Achieves 52-Week High Amid Broader Market Challenges and Sector Underperformance

(22 May 2025)
Aarti Pharmalabs has reached a new 52-week high, reflecting its strong financial health with a low Debt to EBITDA ratio and impressive...
Read more →

Aarti Pharmalabs Achieves 52-Week High Amid Positive Market Trends and Strong Performance Metrics

(21 May 2025)
Aarti Pharmalabs has achieved a new 52-week high in its stock price, reflecting strong performance in the pharmaceutical sector.
Read more →